Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
Hakonarson H, Thorvaldsson S, Helgadottir A, Gudbjartsson D, Zink F, Andresdottir M, Manolescu A, Arnar DO, Andersen K, Sigurdsson A, Thorgeirsson G, Jonsson A, Agnarsson U, Bjornsdottir H, Gottskalksson G, Einarsson A, Gudmundsdottir H, Adalsteinsdottir AE, Gudmundsson K, Kristjansson K, Hardarson T, Kristinsson A, Topol EJ, Gulcher J, Kong A, Gurney M, Thorgeirsson G, Stefansson K. Hakonarson H, et al. Among authors: gurney m. JAMA. 2005 May 11;293(18):2245-56. doi: 10.1001/jama.293.18.2245. JAMA. 2005. PMID: 15886380 Clinical Trial.
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.
Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, Gudmundsdottir T, Bjarnadottir SM, Einarsson OB, Gudjonsdottir HM, Hawkins M, Gudmundsson G, Gudmundsdottir H, Andrason H, Gudmundsdottir AS, Sigurdardottir M, Chou TT, Nahmias J, Goss S, Sveinbjörnsdottir S, Valdimarsson EM, Jakobsson F, Agnarsson U, Gudnason V, Thorgeirsson G, Fingerle J, Gurney M, Gudbjartsson D, Frigge ML, Kong A, Stefansson K, Gulcher JR. Gretarsdottir S, et al. Among authors: gurney m. Nat Genet. 2003 Oct;35(2):131-8. doi: 10.1038/ng1245. Epub 2003 Sep 21. Nat Genet. 2003. PMID: 14517540 Free article.
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O, Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. Steinthorsdottir V, et al. Among authors: gurney m. Nat Genet. 2007 Jun;39(6):770-5. doi: 10.1038/ng2043. Epub 2007 Apr 26. Nat Genet. 2007. PMID: 17460697 Free article. Clinical Trial.
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.
Tefferi A, Fathima S, Alsugair AKA, Aperna F, Natu A, Abdelmagid MG, Csizmar CM, Gurney M, Lasho TL, Finke CM, Mangaonkar AA, Al-Kali A, Pardanani A, Reichard KK, He R, Gangat N, Patnaik MM. Tefferi A, et al. Among authors: gurney m. Am J Hematol. 2024 Sep 27. doi: 10.1002/ajh.27492. Online ahead of print. Am J Hematol. 2024. PMID: 39329442
Gouty tophi of the pinna.
Gurney M, Morris S, Saw K. Gurney M, et al. BMJ Case Rep. 2024 Aug 30;17(8):e261543. doi: 10.1136/bcr-2024-261543. BMJ Case Rep. 2024. PMID: 39214578 No abstract available.
ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia.
Csizmar CM, Gurney M, Kanagal-Shamanna R, Chien K, Hammond D, Lasho TL, Finke CM, Dean C, Natu A, Mangaonkar AA, Al-Kali A, Gangat N, Tefferi A, Alkhateeb H, Garcia-Manero G, Komrokji RS, Ali NA, Padron E, Montalban-Bravo G, Patnaik MM. Csizmar CM, et al. Among authors: gurney m. Haematologica. 2024 Oct 1;109(10):3419-3425. doi: 10.3324/haematol.2024.285410. Haematologica. 2024. PMID: 38899337 Free PMC article. No abstract available.
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance.
Li M, Baranwal A, Gurney M, Shah SN, Al-Kali A, Alkhateeb H, Foran J, Arana Yi C, Ongie L, Chen D, Mangaonkar A, McCullough K, Tefferi A, Lasho T, Finke C, Patnaik MM, Shah MV. Li M, et al. Among authors: gurney m. Blood Adv. 2024 Jun 25;8(12):3130-3139. doi: 10.1182/bloodadvances.2023012357. Blood Adv. 2024. PMID: 38564774 Free PMC article.
230 results